Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis (Q28360820)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

The Effect of "Tween 80" in Vitro on the Bacteriostatic Activity of Twenty Compounds for Mycobacterium tuberculosis.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Rapid drug-susceptibility testing of Mycobacterium tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Clinical evaluation of ethambutol in pulmonary tuberculosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Influence of the medium on the in vitro susceptibility of Mycobacterium tuberculosis to ethambutol

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

A clinical trial of ethambutol plus capreomycin in the treatment of atypical tuberculosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Bactericidal Activity of Streptomycin, Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Alone and In Combination Against Mycobacterium Tuberculosis1

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Observations on the action of rifampin and ethambutol alone and in combination with other antituberculous drugs.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Mode of action of ethambutol on Mycobacterium tuberculosis, strain H37R V.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180621

Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis

27 November 2018

1 reference

12 December 2020

Metabolic and special studies of ethambutol in normal volunteers and tuberculous patients

1 reference

12 December 2020

Comparison of ethambutol-INH versus INH-PAS in original treatment of pulmonary tuberculosis

1 reference

12 December 2020

Treatment of disease due to Mycobacterium intracellulare

1 reference

12 December 2020

Studies on the antituberculous activity of ethambutol in monkeys

1 reference

12 December 2020

A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol)

1 reference

12 December 2020

Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol

1 reference

12 December 2020

B663 and ethambutol in the treatment of Battey disease

1 reference

12 December 2020

Effect of ethambutol on Mycobacteria

1 reference

12 December 2020

Long-term results of medical treatment in Mycobacterium intracellulare infection

1 reference

12 December 2020